ArticleInflammopharmacology2024

Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis.

Mehrnoosh Pashaei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.